Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
66 hedge funds and large institutions have $13.7M invested in Avid Bioservices, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 13 closing their positions.
13% more capital invested
Capital invested by funds: $12.1M → $13.7M (+$1.55M)
13% less funds holding
Funds holding: 76 → 66 (-10)
40% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 20
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$427K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$197K |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$90.9K |
| 4 |
D.E. Shaw & Co
New York
|
+$87.7K |
| 5 |
Goldman Sachs
New York
|
+$18K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$311K |
| 2 |
LCM
Laurion Capital Management
New York
|
-$242K |
| 3 |
Millennium Management
New York
|
-$235K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$159K |
| 5 |
PA
Perceptive Advisors
New York
|
-$76.7K |
CDMO Hedge Fund Activity: Q3 2016 in Review
66 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q3 2016, worth a combined $13.7M — up 13% from $12.1M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of CDMO and 3 opened new positions — a net loss of 10 holders — while 20 trimmed existing stakes and 12 added.
The largest buyer was Renaissance Technologies, adding an estimated $427K. The largest seller was Paloma Partners, exiting entirely with an estimated $311K sold.
- 66 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q3 2016, down from 76 in Q2 2016.
- Funds reported $13.7M of Avid Bioservices, Inc. Common Stock stock for Q3 2016, up 13% quarter-over-quarter.
- 3 funds opened new Avid Bioservices, Inc. Common Stock positions in Q3 2016 and 13 closed out, a net change of -10 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q3 2016 was Renaissance Technologies, an estimated $427K added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q3 2016 was Paloma Partners, an estimated $311K sold.
Based on aggregated 13F filings for Q3 2016.